Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
78,757,060
-
Share change
-
+1,041,461
-
Total reported value
-
$11,461,535,697
-
Put/Call ratio
-
210%
-
Price per share
-
$145.58
-
Number of holders
-
315
-
Value change
-
+$122,756,473
-
Number of buys
-
146
-
Number of sells
-
147
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q3 2021
As of 30 Sep 2021 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) had 315 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 78,757,060 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, BAILLIE GIFFORD & CO, ARK Investment Management LLC, 12 West Capital Management LP, Meritech Capital Associates V L.L.C., Foresite Capital Management II, LLC, and STATE STREET CORP.
This table shows 316 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.